Contineum Therapeutics, Inc. Class A Common Stock

NASDAQ:CTNM

Biotechnology

Healthcare
$9.24 -3.20%

-$0.39 today

Market cap
$326.66M
Beta
0.89
P/E (TTM)
-7.5
EPS (TTM)
-$1.57
52W Low $3.69High $16.33

Volume 0.20M

Average 0.26M

Balance Sheet

Inspect the capital base behind the business.

Assets

$276.64M

FY 2025 · Annual

+30.0% YoY

Liabilities

$15.65M

FY 2025 · Annual

+5.9% YoY

Equity

$260.99M

FY 2025 · Annual

+31.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents4.63M5.57M15.53M21.94M75.6M
Short-term Investments64.37M41.67M109.66M182.82M187.29M
Net Receivables00000
Inventory00000
Other Current Assets775K1.15M2.52M1.63M5.02M
Total Current Assets69.78M48.39M127.71M206.39M267.92M
Property, Plant & Equipment (Net)642K2.12M1.4M6.46M8.47M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets97K129K1.28M3K256K
Total Non-current Assets739K2.24M2.68M6.46M8.73M
Total Assets70.52M50.64M130.39M212.85M276.64M
Account Payables660K430K635K1.81M1.02M
Short-term Debt1.25M3.95M000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities79K1.31M2.48M3.37M1.59M
Total Current Liabilities3.67M7.55M5.48M9.97M9.74M
Long-term Debt3.66M0192.62M00
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.6M3.03M110K00
Total Non-current Liabilities5.26M3.82M192.84M4.81M5.91M
Total Liabilities8.93M11.37M198.32M14.78M15.65M
Common Stock12K12K2K26K37K
Retained Earnings(73.61M)(97.86M)(75.14M)(117.4M)(177.38M)
Accumulated OCI(35K)(76K)108K71K260K
Other Stockholders Equity(0)(0)000
Minority Interest00000
Total Equity61.59M39.27M(67.94M)198.07M260.99M
Total Debt4.91M5.85M193.19M6.26M8.25M
Net Debt279K280K177.67M(15.68M)(67.35M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$20.2M
Short-term Investments$226.2M
Other Current$6.6M
Total Current Assets$253.0M
PP&E (Net)$8.1M
Other Non-current$312.0K
Total Non-current Assets$8.4M
Total Assets$261.3M

Analysis

Selected assets total $261.3M for Latest. The largest visible component is Short-term Investments at $226.2M, about 86.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 6, 2026
SC 13GSC 13G filingNov 5, 2026
10-QQuarterly reportNov 3, 2026
8-KCurrent reportNov 3, 2026
SC 13GSC 13G filingOct 28, 2026

How much cash does CTNM have?

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) reported $75.60M in cash and equivalents in fiscal 2025.

How much debt does CTNM carry?

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) reported $8.25M of total debt, with net debt of -$67.35M.